COAGULATION FACTOR VIIA RECOMBINANT HUMAN for Product used for unknown indication: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 97 adverse event reports in the FDA FAERS database where COAGULATION FACTOR VIIA RECOMBINANT HUMAN was used for Product used for unknown indication.
Most Reported Side Effects for COAGULATION FACTOR VIIA RECOMBINANT HUMAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 169 | 17.8% | 85 | 50 |
| Haemorrhage | 129 | 13.6% | 21 | 53 |
| Drug ineffective | 117 | 12.3% | 26 | 47 |
| Death | 85 | 8.9% | 85 | 8 |
| Pre-existing disease | 78 | 8.2% | 78 | 22 |
| Therapy partial responder | 78 | 8.2% | 76 | 23 |
| Acquired haemophilia | 72 | 7.6% | 70 | 23 |
| Haemarthrosis | 47 | 4.9% | 3 | 27 |
| Haematoma | 30 | 3.2% | 3 | 21 |
| Therapy responder | 30 | 3.2% | 27 | 22 |
| Thrombosis | 27 | 2.8% | 6 | 12 |
| Condition aggravated | 23 | 2.4% | 8 | 11 |
| Shock haemorrhagic | 20 | 2.1% | 14 | 8 |
| Epistaxis | 19 | 2.0% | 0 | 13 |
| Haemorrhage intracranial | 19 | 2.0% | 7 | 8 |
Other Indications for COAGULATION FACTOR VIIA RECOMBINANT HUMAN
Acquired haemophilia (244)
Factor viii deficiency (130)
Haemorrhage (92)
Prophylaxis (54)
Factor vii deficiency (51)
Haemophilia (44)
Haemophilia a with anti factor viii (43)
Factor ix deficiency (36)
Haemostasis (30)
Off label use (26)
Other Drugs Used for Product used for unknown indication
OXYCODONE (129,391)
ADAPALENE (91,681)
APIXABAN (88,417)
ETANERCEPT (71,866)
SACUBITRIL\VALSARTAN (69,693)
ACETAMINOPHEN (68,427)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206)
ADALIMUMAB (63,549)
EVOLOCUMAB (60,696)
MORPHINE (59,440)